IL213589A - Annotations [d – 4 ′, 3 ′; d – 2,3] Pyrolysis, preparation and pharmaceutical preparations containing them - Google Patents

Annotations [d – 4 ′, 3 ′; d – 2,3] Pyrolysis, preparation and pharmaceutical preparations containing them

Info

Publication number
IL213589A
IL213589A IL213589A IL21358911A IL213589A IL 213589 A IL213589 A IL 213589A IL 213589 A IL213589 A IL 213589A IL 21358911 A IL21358911 A IL 21358911A IL 213589 A IL213589 A IL 213589A
Authority
IL
Israel
Prior art keywords
dipyrido
preparation
pharmaceutical compositions
compositions containing
pyrrol derivatives
Prior art date
Application number
IL213589A
Other languages
English (en)
Hebrew (he)
Other versions
IL213589A0 (en
Inventor
Brugger Nadia
Charles Victor Jones Christopher
E Sutton Amanda
C Askew Benny Jr
R Huck Bayard
R Smith Garry
Original Assignee
Brugger Nadia
Charles Victor Jones Christopher
Merck Patent Gmbh
E Sutton Amanda
C Askew Benny Jr
R Huck Bayard
R Smith Garry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brugger Nadia, Charles Victor Jones Christopher, Merck Patent Gmbh, E Sutton Amanda, C Askew Benny Jr, R Huck Bayard, R Smith Garry filed Critical Brugger Nadia
Publication of IL213589A0 publication Critical patent/IL213589A0/en
Publication of IL213589A publication Critical patent/IL213589A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL213589A 2008-12-18 2011-06-16 Annotations [d – 4 ′, 3 ′; d – 2,3] Pyrolysis, preparation and pharmaceutical preparations containing them IL213589A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20302208P 2008-12-18 2008-12-18
PCT/US2009/066534 WO2010080253A1 (en) 2008-12-18 2009-12-03 Tricyclic azaindoles

Publications (2)

Publication Number Publication Date
IL213589A0 IL213589A0 (en) 2011-07-31
IL213589A true IL213589A (en) 2016-02-29

Family

ID=41682740

Family Applications (1)

Application Number Title Priority Date Filing Date
IL213589A IL213589A (en) 2008-12-18 2011-06-16 Annotations [d – 4 ′, 3 ′; d – 2,3] Pyrolysis, preparation and pharmaceutical preparations containing them

Country Status (8)

Country Link
US (1) US8853391B2 (cg-RX-API-DMAC10.html)
EP (1) EP2367822B1 (cg-RX-API-DMAC10.html)
JP (2) JP2012512871A (cg-RX-API-DMAC10.html)
AU (1) AU2009336040B2 (cg-RX-API-DMAC10.html)
CA (1) CA2745085C (cg-RX-API-DMAC10.html)
ES (1) ES2603208T3 (cg-RX-API-DMAC10.html)
IL (1) IL213589A (cg-RX-API-DMAC10.html)
WO (1) WO2010080253A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2734552T3 (es) 2010-04-16 2019-12-10 Ac Immune Sa Compuestos novedosos para el tratamiento de enfermedades asociadas a proteínas amiloides o de tipo amiloide
BR112015021386A2 (pt) * 2013-03-14 2017-07-18 Bristol Myers Squibb Co moduladores de ácido biciclo [2.2.2] gpr120
GB201704325D0 (en) * 2017-03-17 2017-05-03 Argonaut Therapeutics Ltd Compounds
CN111757882B (zh) 2018-01-05 2023-08-22 Ac免疫有限公司 用于治疗、减轻或预防与Tau聚集体相关的病症的化合物
CN112313230B (zh) * 2018-06-04 2024-03-15 Ac免疫有限公司 用于治疗、缓解或预防与Tau聚集体相关的病症的新型化合物
EA202091395A1 (ru) * 2018-06-04 2020-10-01 Ас Иммьюн Са ПРОИЗВОДНЫЕ 1,3,4,5-ТЕТРАГИДРО-2Н-ПИРИДО[4,3-b]ИНДОЛА ДЛЯ ЛЕЧЕНИЯ, ОБЛЕГЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ РАССТРОЙСТВ, СВЯЗАННЫХ С АГРЕГАТАМИ ТАУ, ТАКИХ КАК БОЛЕЗНЬ АЛЬЦГЕЙМЕРА
EP3836919A4 (en) 2018-08-16 2022-05-18 Recreo Pharmaceuticals Inc. 1,3,4,9-tetrahydro-2h-pyrido[3,4-b]indole derivative compounds and uses thereof
CA3131805C (en) 2019-03-01 2023-11-21 Ac Immune Sa Novel compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268771A (en) * 1968-03-15 1972-03-29 Glaxo Lab Ltd Azacarbazoles
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
CA2242425C (en) 1996-02-13 2006-07-18 Zeneca Limited Quinazoline derivatives as vegf inhibitors
NZ331191A (en) 1996-03-05 2000-03-27 Zeneca Ltd 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
US6589954B1 (en) * 1998-05-22 2003-07-08 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
BR0111230A (pt) 2000-05-31 2003-06-10 Astrazeneca Ab Composto, e, uso e processo para a preparação do mesmo
KR20030014425A (ko) 2000-07-07 2003-02-17 앤지오젠 파마슈티칼스 리미티드 혈관 손상제인 콜치놀 유도체
EE200300015A (et) 2000-07-07 2004-10-15 Angiogene Pharmaceuticals Limited Kolhinooli derivaadid kui angiogeneesi inhibiitorid
US20040014676A1 (en) * 2001-07-09 2004-01-22 Ramalinga Dharanipragada SRC kinase inhibitors useful for treating osteoporosis
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
US8119655B2 (en) * 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
JP2010500961A (ja) * 2006-08-02 2010-01-14 武田薬品工業株式会社 α−カルボリン誘導体およびその製造方法
CN101687864A (zh) * 2007-06-26 2010-03-31 阿斯利康(瑞典)有限公司 作为组织蛋白酶k抑制剂的1-氰基环丙基-衍生物
RU2007139634A (ru) * 2007-10-25 2009-04-27 Сергей Олегович Бачурин (RU) Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения

Also Published As

Publication number Publication date
AU2009336040B2 (en) 2015-07-16
WO2010080253A1 (en) 2010-07-15
US20120022060A1 (en) 2012-01-26
EP2367822B1 (en) 2016-10-05
US8853391B2 (en) 2014-10-07
JP2015187155A (ja) 2015-10-29
JP6109880B2 (ja) 2017-04-05
JP2012512871A (ja) 2012-06-07
AU2009336040A1 (en) 2011-06-30
CA2745085C (en) 2018-03-06
CA2745085A1 (en) 2010-07-15
EP2367822A1 (en) 2011-09-28
IL213589A0 (en) 2011-07-31
ES2603208T3 (es) 2017-02-24

Similar Documents

Publication Publication Date Title
IL213993A (en) History of 4,3,2,1-tetrahydropyrido [3,2-b] pyrazine-2-one and pharmaceutical preparations containing them
IL220432A (en) History of theo [b – 3,2] pyridinedione and pharmaceutical preparations containing them
IL213589A0 (en) DIPYRIDO [2,3-d;4-d] PYRROL DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL200695A (en) History of Hydro-Oxazolo [2,3-a] Pyrimidine-7-Wen and Pharmaceutical Preparations Containing Them
IL193141A (en) Compounds including pyrrolo [2,3– d] pyrimidine 7 - yl and sulphamate, pharmaceuticals and their use
IL211693A (en) Annotations3 –– Cyano – 6– (Amino Converted) –8– (Optionally Converted Amino) –Imidazo [2,1– b] Pyridazine and Pharmaceuticals Containing Them
AP2010005347A0 (en) Novel pyrazolo [3,4-D] pyrimidine derivatives as anti-cancer agents
IL219424A (en) Imidazo derivative [b – 1,2] pyridazine, combinations, distant preparations containing them and process for their preparation and use as pde10 inhibitors
PL2364983T3 (pl) Nowa pochodna tricykliczna lub jej farmaceutycznie dopuszczalne sole, sposób jej wytwarzania, oraz zawierająca ją kompozycja farmaceutyczna
IL215911A (en) 7-aryl-1,2,4-triazolo [3,4- a] derivatives, pharmaceutical preparations containing them and methods of preparation and uses thereof
IL215644A (en) N-phenylsulfonyl-2- (h1-pyrrolo [3,2- b] pyridine-5-yloxy) benzamide and anticancer drugs containing them
IL209258A (en) Derivatives of Pyrolopyridine, Pharmaceutical Preparations Containing Them, Processes for their Preparation and Uses
IL220913A (en) Puro [2,3– b] pyran derivatives are useful in the synthesis of compounds similar to halochondrine b
ZA201100429B (en) Novel imidazo [1,2-a]pyrimidine derivatives,method for the preparation thereof,use thereof as medicaments,pharmaceutical compositions and novel use in particular as met inhibitors
IL210377A (en) History of Naphthyridone, their preparation and their pharmaceutical preparations
IL215158A (en) History of imidazo [1,2– b] [4,3,1] thadiazole preserved in positions 2 and 5, a process for preparing them and their pharmaceutical preparations
IL205189A (en) 7,6-dihydro-h5-imidazo [2,1- α] imidazole-3-carboxamide and their pharmaceutical preparations
PT2448940E (pt) Derivados de 6,7,8,9-tetra-hidro-pirimido{1,2-α} pirimidin- 4-ona, sua preparação e sua utilização farmacêutica
IL219371A (en) Ethylene History - (s-Triazolo / Pyrzolo) [a – 5,1] (Pyridine / Pyrimidine) and Pharmaceuticals Containing Them
IL206673A0 (en) Imidazo[1,2-a]pyridine-2-carboxamide derivatives, their preparation and their therapeutic application
SG10201403138WA (en) Novel 2,3-dihydro-1h-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof and pharmaceutical use thereof
IL212942A (en) History of Rifamycin, Methods of Preparation, Pharmaceutical Preparations Containing Them and Their Uses
ZA200907416B (en) Pyrimido [4,5-D] azepine derivatives as 5-HT2C agonists
HUP0700395A2 (en) Substituted [1,2,4] triazolo [1,5-a] quinolines, process for their preparation, pharmaceutical compositions thereof, and intermediates
IL206671A0 (en) N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed